Valneva SE

VALN Nasdaq SEC CIK 1836564
Follow Valneva Weekly email: filings, results

Financials

Reported figures only · latest: Q4 2025 EUR · IFRS
Revenue, last quarter €47.7M −9.9% vs same quarter last year
Net income −€50M −35.2% vs same quarter last year
EPS, diluted -
Operating cash flow −€24.5M −357.3% vs same quarter last year
Revenue by quarter
€32.8M
€38.1M
€45.8M
€52.9M
€49.2M
€48.3M
€29.4M
€47.7M
Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, IFRS
Revenue and net income8 fiscal years
  • Revenue
  • Net income
−€200M€0€200M€400MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25€174.7M−€115.2M
FY24€169.6M−€12.2M
FY23€153.7M−€101.4M
FY22€361.3M−€143.3M
FY21€348.1M−€61.4M
FY20€110.3M−€55.1M
FY19€126.2M−€811K
FY18--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−100%−50%0%50%100%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2538.7%−47%−66%
FY2441.9%7.9%−7.2%
FY2334.4%−53.4%−66%
FY2210.2%−31.4%−39.7%
FY2146%−17.6%−17.6%
FY2050.8%−50%−50%
FY1958.2%−0.6%−0.6%
FY18---
Free cash flowOperating cash flow minus capital expenditure
−€300M−€200M−€100M€0€100M€200MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−€57.3M
FY24−€81.1M
FY23−€217M
FY22−€274.6M
FY21−€15.3M
FY20€118.8M
FY19−€5M
FY18-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Valneva
  • Healthcare median
−100%−75%−50%−25%0%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearValnevaHealthcare median
FY25−66%−30.6%
FY24−7.2%−47%
FY23−66%−58%
FY22−39.7%−80.4%
FY21−17.6%−71.9%
FY20−50%−62.2%
FY19−0.6%−46.3%
FY18-−49.6%